BIOMAT Database Logo BIOMAT Database Logo

Population pharmacokinetics of abacavir in plasma and cerebrospinal fluid. 2005

Edmund V Capparelli, and Scott L Letendre, and Ronald J Ellis, and Parul Patel, and Diane Holland, and J Allen McCutchan
Pediatric Pharmacology Research Unit (PPRU), University of California, San Diego, 200 West Arbor Drive, MC 8214, San Diego, CA 92103-8214, USA. ecapparelli@ucsd.edu

The distribution of abacavir into the cerebrospinal fluid (CSF) was assessed by use of a population pharmacokinetic analysis. Plasma and CSF abacavir concentrations in 54 subjects were determined. The abacavir CSF/plasma ratio averaged 36% and increased throughout the dose interval. Abacavir penetrates into the CSF in adequate concentrations to inhibit local human immunodeficiency virus replication.

UI MeSH Term Description Entries
D008297 Male Males
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012984 Software Sequential operating programs and data which instruct the functioning of a digital computer. Computer Programs,Computer Software,Open Source Software,Software Engineering,Software Tools,Computer Applications Software,Computer Programs and Programming,Computer Software Applications,Application, Computer Software,Applications Software, Computer,Applications Softwares, Computer,Applications, Computer Software,Computer Applications Softwares,Computer Program,Computer Software Application,Engineering, Software,Open Source Softwares,Program, Computer,Programs, Computer,Software Application, Computer,Software Applications, Computer,Software Tool,Software, Computer,Software, Computer Applications,Software, Open Source,Softwares, Computer Applications,Softwares, Open Source,Source Software, Open,Source Softwares, Open,Tool, Software,Tools, Software
D015224 Dideoxynucleosides Nucleosides that have two hydroxy groups removed from the sugar moiety. The majority of these compounds have broad-spectrum antiretroviral activity due to their action as antimetabolites. The nucleosides are phosphorylated intracellularly to their 5'-triphosphates and act as chain-terminating inhibitors of viral reverse transcription. 2',3'-Dideoxynucleosides,Dideoxyribonucleosides,ddNus,2',3' Dideoxynucleosides
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse

Related Publications

Edmund V Capparelli, and Scott L Letendre, and Ronald J Ellis, and Parul Patel, and Diane Holland, and J Allen McCutchan
Plasma and cerebrospinal fluid population pharmacokinetics of temozolomide in malignant glioma patients.
June 2004, Clinical cancer research : an official journal of the American Association for Cancer Research,
Edmund V Capparelli, and Scott L Letendre, and Ronald J Ellis, and Parul Patel, and Diane Holland, and J Allen McCutchan
Meropenem Population Pharmacokinetics and Simulations in Plasma, Cerebrospinal Fluid, and Brain Tissue.
August 2022, Antimicrobial agents and chemotherapy,
Edmund V Capparelli, and Scott L Letendre, and Ronald J Ellis, and Parul Patel, and Diane Holland, and J Allen McCutchan
Pharmacokinetics of pirarubicin in plasma and cerebrospinal fluid.
February 1998, The Annals of pharmacotherapy,
Edmund V Capparelli, and Scott L Letendre, and Ronald J Ellis, and Parul Patel, and Diane Holland, and J Allen McCutchan
Pharmacokinetics of methotrexate in plasma and cerebrospinal fluid.
October 1997, The Annals of pharmacotherapy,
Edmund V Capparelli, and Scott L Letendre, and Ronald J Ellis, and Parul Patel, and Diane Holland, and J Allen McCutchan
Paracetamol plasma and cerebrospinal fluid pharmacokinetics in children.
September 1998, British journal of clinical pharmacology,
Edmund V Capparelli, and Scott L Letendre, and Ronald J Ellis, and Parul Patel, and Diane Holland, and J Allen McCutchan
Population pharmacokinetics of oxycodone in plasma and cerebrospinal fluid after epidural and intravenous administration.
June 2019, Expert opinion on drug delivery,
Edmund V Capparelli, and Scott L Letendre, and Ronald J Ellis, and Parul Patel, and Diane Holland, and J Allen McCutchan
Plasma and Cerebrospinal Fluid Population Pharmacokinetics of Vancomycin in Patients with External Ventricular Drain.
June 2023, Antimicrobial agents and chemotherapy,
Edmund V Capparelli, and Scott L Letendre, and Ronald J Ellis, and Parul Patel, and Diane Holland, and J Allen McCutchan
Plasma and cerebrospinal fluid pharmacokinetics of ondansetron in humans.
February 2021, British journal of clinical pharmacology,
Edmund V Capparelli, and Scott L Letendre, and Ronald J Ellis, and Parul Patel, and Diane Holland, and J Allen McCutchan
Plasma and cerebrospinal fluid pharmacokinetics of naproxen in children.
October 2012, Journal of clinical pharmacology,
Edmund V Capparelli, and Scott L Letendre, and Ronald J Ellis, and Parul Patel, and Diane Holland, and J Allen McCutchan
Plasma and cerebrospinal fluid pharmacokinetics of flurbiprofen in children.
October 2010, British journal of clinical pharmacology,
Copied contents to your clipboard!